AC Immune SA (ACIU) Reports Q1 Loss of $0.15

AC Immune SA (NASDAQ: ACIU) reported Q1 EPS of ($0.15). Revenue for the quarter came in at $1.12 million versus the consensus estimate of $404.63 thousand.

For earnings history and earnings-related data on AC Immune SA (ACIU) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Boost Run posts Q2 revenue of $31.1M, up 270% year over year
• Reddit to join S&P 500 index on Aug. 18, shares leap